Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 367 of 5804
-
New drug combo aims to keep bladder cancer from coming back
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of the study medicine (Disitamab Vedotin) in people with non-muscle invasive bladder cancer. This study is seeking participants whose bladder cancer is still in early stages, has not spread outside of the bladder,…
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for IBD patients: IL-23 blocker aims for Steroid-Free remission
Disease control Recruiting nowPatients diagnosed with moderate to severe CD or UC by the end of the study period were selected. After obtaining informed consent, treatment with infliximab-based drugs was initiated. Basic patient information and medical history were collected. The treatment process was followe…
Phase: PHASE4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Massive stroke trial aims to cut deadly delays in china
Knowledge-focused Recruiting nowStroke is the main cause of death and disability in China, but it is preventable and treatable. For the most common type, acute ischemic stroke (AIS), initiating reperfusion therapy with intravenous thrombolysis (IVT) with or without mechanical thrombectomy (MT) within several ho…
Phase: NA • Sponsor: Shanghai Minhang Central Hospital • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New surgery aims to stop lymphedema before it starts
Prevention Recruiting nowImmediate lymphatic reconstruction (ILR) is a novel surgical approach performed at the time of initial lymph node dissection with the goal of preventing lymphedema.(Chang et al. 2020) It involves the identification of lymphatic channels that are transected after lymph node dissec…
Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
New targeted pill may keep ALK lung cancer in check after standard treatment
Disease control Not yet recruitingThe PACIFIC study established the standard of care for immunotherapy consolidation after chemoradiotherapy (CRT) in patients with unresectable stage III non-small cell lung cancer (NSCLC). However, its benefit is limited in patients with driver gene mutations. The LAURA study est…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New Immunotherapy-Chemo cocktail aims to boost cervical cancer survival
Disease control Not yet recruitingThis is a single-arm, phase II clinical trial evaluating the efficacy and safety of neoadjuvant Ivonescimab combined with paclitaxel and cisplatin (TP regimen), followed by concurrent chemoradiotherapy, in patients with high-risk, locally advanced cervical cancer (FIGO stage III-…
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
CLL patients may soon stop daily pills: new combo aims for Fixed-Duration treatment
Disease control Recruiting nowThis is an open-label, multicenter, phase 2, non-randomized study aiming to study the efficacy and safety of fixed-duration venetoclax consolidation in CLL patients who are on BTK inhibitor monotherapy. Patients who are on BTK inhibitor monotherapy for ≥ 6 months and still respon…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
AI breakthrough: predicting breast Cancer's next move
Knowledge-focused Recruiting nowBreast cancer is one of the most common malignancies in women worldwide, and distant metastasis is the main cause of poor prognosis and death. This project aims to construct a precision prediction system based on multi-omics (digital pathology, immunohistochemistry, proteomics, g…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Can a double dose stop Post-Procedure pancreatitis?
Prevention Not yet recruitingOur aim is to compare the efficacy of 100 mg versus 200 mg rectal indometacin in preventing post-ERCP pancreatitis (PEP) among high-risk patients without no pancreatic stenting. The 100 mg versus 200 mg indometacin trial is a multicentre, single-blind, randomized controlled study…
Phase: PHASE4 • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Radioactive seeds aim to boost Chemo's punch against breast cancer
Disease control Not yet recruitingThis study is an open-label, controlled, multicenter phase III clinical trial designed to evaluate whether the use of iodine-125 radioactive seed markers can improve treatment response for patients with early or locally advanced breast cancer undergoing neoadjuvant therapy. Neoa…
Phase: PHASE3 • Sponsor: Pengfei Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Shorter radiation may be just as good for rectal cancer patients
Disease control Not yet recruitingThis study compares two standard radiotherapy approaches (short-course vs. long-course) given before surgery in patients with locally advanced rectal cancer. The goal is to see which treatment is more effective and better tolerated.
Phase: NA • Sponsor: Rajiv Gandhi Cancer Institute & Research Center, India • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Radiation plus Chemo-Immunotherapy shows promise in High-Risk breast cancer trial
Disease control Not yet recruitingThis study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy and safety of combining radiotherapy, chemotherapy, and immunotherapy in the neoadjuvant treatment of high-risk HR+/HER2- breast cancer patients. The study plans to enroll treatme…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can a pregnancy vaccine shield newborns from RSV? new study investigates
⭐️ VACCINE ⭐️ OngoingTo generate critical evidence to support vaccine policy and implementation, Pfizer will collaborate with Kaiser Permanente Northern California (KPNC) to study the vaccine effectiveness (VE) of ABRYSVO vaccination during pregnancy in a real-world population. The overall research q…
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:08 UTC
-
Could a simple breath test catch stomach cancer early?
Diagnosis Not yet recruitingCancer of the stomach and oesophagus is among the world's top five cancers. Survival rates are very poor as the disease presents late and early symptoms are non-specific. The study team has developed a non-invasive test for cancers of the stomach and oesophagus based on the detec…
Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
New mRNA vaccine targets brain tumors in early trial
Disease control Recruiting nowThis clinical trial is designed to evaluate the safety and efficacy of a universal mRNA vaccine targeting a panel of glioma-associated mutations in patients with recurrent or progressive high-grade glioma. The primary objectives are to address the following key questions: 1) Is …
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy aims to save rectums in advanced cancer
Disease control Recruiting nowIn a single-center, prospective, phase II study (ClinicalTrials registration number: \[to be filled in\]) initiated by our center to evaluate the safety and preliminary efficacy of short-course radiotherapy followed by sequential CAPOX chemotherapy combined with serplulimab and b…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
HIV counselors lead new push to offer prevention pills at family planning visits
Prevention Recruiting nowThis is a cluster randomized, stepped wedge implementation study to introduce HIV testing services (HTS) counselor-led PrEP care in public health clinics in Kenya.
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Could a smart device at home tame Post-Surgery pain and prevent chronic pain?
Disease control Recruiting nowAcute postoperative pain (APOP) is a major public health problem, affecting nearly 10 million patients in France each year. Effective analgesic therapy in the first postoperative week is a key factor in reducing early postoperative morbidity and mortality. Poorly controlled APOP …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Heart failure hope for kids: diabetes drug tested as new therapy
Disease control Recruiting nowthe study to investigate the efficacy of empagiflozin in pediatric heart failure
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Simple surgical trick may prevent dangerous heart rhythm after bypass or valve surgery
Prevention Recruiting nowPRINCE-CH is a multicentre, randomized controlled trial which evaluates the effectiveness and safety of posterior pericardiotomy in preventing POAF after cardiac surgery in Chinese population.
Phase: NA • Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC